Jonathan B Blitzer

Jonathan B. Blitzer, MD is a Professor in the Division of Hematology and Oncology at the University of California, Irvine (UCI) School of Medicine. His research focuses on precision medicine and cancer therapeutics, particularly through functional platforms analyzing drug-induced cell death in tumor models.

Research interests include:

• Non-Small Cell Lung Cancer (NSCLC) treatment
• Tumor micro-spheroid culture systems
• Personalized chemotherapy protocols
• Metastatic cancer drug response prediction

Recent publications highlight his work on:

• 3D explant models for therapeutic targeting of P53
• Spheroid cultures in colorectal and breast cancer
• Improving response rates in advanced NSCLC
• Mechanistic studies of metabolic therapies (e.g., metformin)